J. Certoux

发表

Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graft.

Craig W. Reynolds, D. Longo, E. Deconinck, 2001, Blood.

Development of a competitive PCR method for in vitro and in vivo quantification of herpes simplex virus thymidine kinase and neomycin resistance-expressing cells used in a clinical trial.

P. Tiberghien, C. Ferrand, P. Hervé, 2000, Journal of hematotherapy & stem cell research.

Retrovirus-mediated gene transfer in primary T lymphocytes: influence of the transduction/selection process and of ex vivo expansion on the T cell receptor beta chain hypervariable region repertoire.

E. Robinet, P. Tiberghien, C. Ferrand, 2000, Human gene therapy.

Exposure to hypomethylating agent, 5-azacytidine, may improve iCasp9 suicide gene therapy for treating GvHD in allografts

M. Deschamps, E. Deconinck, P. Tiberghien, 2016, Gene Therapy.

Use of a Closed Culture System to Improve the Safety of Lentiviral Vector Production.

J. Marescaux, D. Mutter, M. Diana, 2015, Human Gene Therapy Methods.

Alloreactivity of ex vivo-expanded T cells is correlated with expansion and CD4/CD8 ratio.

E. Robinet, P. Tiberghien, C. Ferrand, 2008, Cytotherapy.

In situ delivery of allogeneic natural killer cell (NK) combined with Cetuximab in liver metastases of gastrointestinal carcinoma: A phase I clinical trial

P. Morel, X. Pivot, P. Tiberghien, 2018, Oncoimmunology.

gene-modified T cells infused with a hematopoietic graft Deletions within the HSV-tk transgene in long-lasting circulating

Carole Henry, M. Deschamps, E. Robinet, 2013 .

Deletions within the HSV-tk transgene in long-lasting circulating gene-modified T cells infused with a hematopoietic graft.

Carole Henry, M. Deschamps, E. Deconinck, 2007, Blood.

Ganciclovir treatment of herpes simplex thymidine kinase-transduced primary T lymphocytes: an approach for specific in vivo donor T-cell depletion after bone marrow transplantation?

Craig W. Reynolds, M. Deschaseaux, Y. Chiang, 1994, Blood.

Retrovirus-mediated gene transfer in human primary T lymphocytes induces an activation- and transduction/selection-dependent TCR-B variable chain repertoire skewing of gene-modified cells.

E. Robinet, P. Tiberghien, C. Ferrand, 2004, Stem cells and development.

Retrovirus-mediated transfer of the herpes simplex type I thymidine kinase gene in alloreactive T lymphocytes.

Craig W. Reynolds, Y. Chiang, P. Tiberghien, 1998, Human Gene Therapy.

Preferential retroviral-mediated transduction of EBV- and CMV-specific T cells after polyclonal T-cell activation

N. Taylor, P. Tiberghien, C. Ferrand, 2004, Gene Therapy.

First immunotherapeutic CAR-T cells against the immune checkpoint protein HLA-G

P. Souque, J. LeMaoult, M. Loustau, 2021, Journal for ImmunoTherapy of Cancer.

Early immune response against retrovirally transduced herpes simplex virus thymidine kinase-expressing gene-modified T cells coinfused with a T cell-depleted marrow graft: an altered immune response?

M. Deschamps, E. Deconinck, P. Tiberghien, 2008, Human gene therapy.

Transcriptome of retrovirally transduced CD8+ lymphocytes: influence of cell activation, transgene integration, and selection process.

T. Rème, J. de Vos, M. Deschamps, 2008, Molecular immunology.

CD28/4-1BB CD123 CAR T cells in blastic plasmacytoid dendritic cell neoplasm

T. Petrella, E. Macintyre, M. Mohty, 2020, Leukemia.

A closed culture system for the ex vivo transduction and expansion of human T lymphocytes.

Craig W. Reynolds, P. Tiberghien, C. Ferrand, 1998, Journal of hematotherapy.

Promoter’s Choice Drive CAR-T Efficiency

F. Garnache-Ottou, P. Charneau, M. Loustau, 2021 .

Evidence that a transient enhancement of endogenous hematopoiesis contributes significantly to the favorable outcome following interleukin 1 pretreatment and allogeneic bone marrow transplantation.

P. Tiberghien, P. Hervé, J. Cahn, 1996, Transplantation.

Abnormal expression of only the CD34 part of a transgenic CD34/herpes simplex virus-thymidine kinase fusion protein is associated with ganciclovir resistance.

M. Deschamps, J. Rémy-Martin, P. Tiberghien, 2008, Human gene therapy.

Transgene Deletions in Long-Term Circulating Donor Gene-Modified T Lymphocytes Infused at Time of Hematopoietic Transplantation.

M. Deschamps, E. Deconinck, P. Tiberghien, 2005 .

Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graft.

Craig W. Reynolds, D. Longo, E. Deconinck, 2001, Blood.